NervGen Pharma Corp.(TSXV:NGEN) dropped from S&P/TSX Venture Composite Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.02 CAD | -3.35% | +1.00% | -25.19% |
Apr. 17 | NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update | MT |
Apr. 17 | NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.19% | 107M | |
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- NGEN Stock
- News NervGen Pharma Corp.
- NervGen Pharma Corp.(TSXV: NGEN) dropped from S&P/TSX Venture Composite Index